Cholinergics (Alpha-GPC, Citicoline)

Navigation

Upward Index: 02 - Compounds & Molecules MOC | Literature Dossier: Cholinergics (Alpha-GPC, Citicoline) - References

---

1. Pharmacodynamics & Mechanism of Action

Cholinergic nootropics enhance central and neuromuscular Acetylcholine (ACh) neurotransmission while supplying structural precursors for neuronal membrane phosphatidylcholine (PC) synthesis.

• Acetylcholine Synthesis (ChAT): In cholinergic nerve terminals (basal forebrain, nucleus basalis of Meynert, hippocampus, and neuromuscular junction), Choline Acetyltransferase (ChAT) catalyzes the condensation of free Choline (imported via the high-affinity CHT1 / SLC5A7 transporter) with Acetyl-CoA (donated by mitochondrial pyruvate dehydrogenase or Acetyl-L-Carnitine / ALCAR).
• Alpha-GPC (L-Alpha-Glycerylphosphorylcholine): Delivers $40.5\%$ choline by weight across the blood-brain barrier (BBB), rapidly elevating hippocampal and cortical ACh release, potentiating ${\text{Ca}}^{2+}$-dependent vesicular exocytosis, and suppressing hypothalamic somatostatin to amplify Growth Hormone (GH) pulses during resistance training.
• Citicoline (CDP-Choline) & The Kennedy Pathway: Hydrolyzed in the gut and liver into Choline ($18.5\%$ by weight) and Cytidine, which converts in humans into Uridine. Uridine crosses the BBB via CNT2 nucleoside transporters, phosphorylates into UTP/CTP, and drives the rate-limiting CTP:phosphocholine cytidylyltransferase step of the Kennedy Pathway—synthesizing phosphatidylcholine, upregulating striatal dopamine $D_2$ receptor density, and increasing tyrosine hydroxylase activity.

---

2. Pharmacokinetics & Choline Donor Comparison

Compound	Choline Content (% wt)	BBB Penetration	Peak Plasma ($T_{\max }$)	Primary Neurochemical Profile
Alpha-GPC	$40.5\%$	Very High	$1\text{–}2\text{ hours}$	Rapid peak ACh surge; neuromuscular power output & GH secretagogue synergy
Citicoline (CDP-Choline)	$18.5\%$	High (Choline + Uridine)	$1.5\text{ h}$ & $24\text{ h}$ (biphasic)	Sustained PC membrane synthesis, brain ATP/PCr elevation ($+7\text{–}14\%$), dopaminergic tone
ALCAR (Acetyl-L-Carnitine)	$0\%$ (Acetyl donor)	High (OCTN2)	$2.5\text{–}3.5\text{ hours}$	Donates the acetyl moiety to ChAT; transports long-chain fatty acids into mitochondria
Choline Bitartrate	$41.1\%$	Low (saturable)	$1\text{–}2\text{ hours}$	Primarily hepatic (PEMT/VLDL export); high conversion by gut microbiota into TMA/TMAO

---

3. Dosing, Cycling & Synergies

• Standard Protocol:
  • Citicoline (Cognizin): $250\text{–}500\text{ mg/day}$ in the morning (ideal for sustained executive function, dopaminergic motivation, and membrane neuroprotection).
  • Alpha-GPC: $300\text{–}600\text{ mg}$ taken $45\text{ min}$ prior to demanding cognitive bouts or physical training (clinical dementia trials utilize $1,200\text{ mg/day}$ in 3 divided doses of $400\text{ mg}$).
  • ALCAR: $500\text{–}1,500\text{ mg}$ fasted in the morning.
• Cycling Cadence: 5 days on / 2 days off (or titrate down if signs of excess central acetylcholine emerge: neck/jaw stiffness, emotional blunting, or depressive lethargy—the Janowsky cholinergic-adrenergic balance hypothesis).
• Synergies:
  • Racetam Stacking: Obligate pairing with Racetams & AMPAkines (which accelerate hippocampal ACh turnover and deplete synaptic choline).
  • The Mr. Happy Stack (Synaptogenesis): Citicoline (or Uridine Monophosphate $150\text{–}250\text{ mg}$) + Omega-3 & Lipid Membrane Health (DHA $1,000\text{ mg}$) + Methylation & B-Complex.
• Contraindications & Biomarkers to Monitor:
  • TMAO Precaution: High-dose oral choline salts (especially bitartrate, and to a lesser extent high-dose chronic Alpha-GPC) can be metabolized by intestinal CutC/D lyases into Trimethylamine (TMA) and oxidized by hepatic FMO3 into TMAO. Mitigate with allicin (aged garlic extract), berberine, or extra-virgin olive oil (DMB), or favor lower-dose Citicoline.
  • Biomarkers: Plasma TMAO, Fasting Homocysteine (choline spares SAMe via BHMT), and Free/Total Carnitine.

---

4. Key Scientific Evidence Summary

• Clinical Cognitive Recovery (Alpha-GPC): De Jesus Moreno Moreno (2003) demonstrated in a 180-day multicenter double-blind RCT ($N=261$) that $1,200\text{ mg/day}$ Alpha-GPC improved ADAS-Cog scores by $+3.2\text{ points}$ while placebo worsened by $-2.9\text{ points}$ ($p<0.001$).
• Cerebral Bioenergetics (Citicoline ${}^{31}\text{P-MRS}$): Silveri et al. (2008) showed in NMR in Biomedicine that 6 weeks of $500\text{ mg/day}$ Citicoline increased anterior cingulate cortex ATP by $+14\%$, Phosphocreatine by $+7\%$, and membrane phospholipid turnover by $+26\text{–}32\%$.
• Power Output & GH Secretion: Ziegenfuss et al. (2008) and Bellar et al. (2015) found that $600\text{ mg}$ Alpha-GPC increased acute exercise-induced GH secretion and isometric mid-thigh pull peak force.

See full study breakdowns in Cholinergics (Alpha-GPC, Citicoline) - References.